Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sitagliptin on Blood Pressure in Metabolic Syndrome
NCT00666848Phase 4Completed
- Sponsor
- Vanderbilt University
- Start
- Mar 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sitagliptin in metabolic syndrome and hypertension (HTN) (3 arms), sponsored by Vanderbilt University. Primary endpoints: Change in Mean Arterial Pressure During Placebo Pretreatment at 8 hours and Change in Mean Arterial Pressure During Sitagliptin Pretreatment at 8 hours. Started Mar 2008; status: completed.
02
Drugs
sitagliptin
03
Conditions
metabolic syndromehypertension (HTN)
Beyond the preview
Go deeper on NCT00666848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666848.